Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate
Information source: University of Sao Paulo
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Snoring; Apnea
Intervention: Injection Snoreplasty (Procedure)
Phase: N/A
Status: Active, not recruiting
Sponsored by: University of Sao Paulo Official(s) and/or principal investigator(s): Fabio TM Lorenzetti, MD, Principal Investigator, Affiliation: University of São Paulo Michel B Cahali, PhD, Study Director, Affiliation: University of São Paulo
Summary
SUMMARY INTRODUCTION: among various treatments for patients with primary snoring, upper
airway resistance syndrome (UARS) and obstructive sleep apnea syndrome (OSAS), the injection
snoreplasty arose as a promising alternative in some selected cases.
OBJECTIVE: to investigate the efficacy and tolerance of injection snoreplasty comparing
Ethanol and Ethanolamine Oleate.
Clinical Details
Official title: Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate. A Randomized, Placebo-Controlled Study in Human Patients
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Primary outcome: Snoring
Eligibility
Minimum age: 18 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Snoring
- RDI < 15 /h
Exclusion Criteria:
- BMI > 35
Locations and Contacts
University of São Paulo, São Paulo, SP, Brazil
Additional Information
Starting date: January 2007
Last updated: December 5, 2008
|